We’re pioneering AI-driven prediction of immunotherapy response

Curenetics uses multimodal clinical and biological data to predict which patients will respond to immunotherapy

Our Vision

At Curenetics, we believe every cancer patient deserves clarity and confidence in their treatment journey.


Our AI-powered prediction platform helps doctors and patients choose the most effective therapies, reducing the risk of ineffective treatments and unnecessary side effects.
By turning data into insight, we bring precision, hope, and better outcomes to every decision in cancer care.

The Challenge

More than 3 million people in the UK have cancer, with 1,000 new cases daily

Even with better treatments, UK survival rates are lower than in other developed countries.

Immunotherapy helps 20–30% of patients, but many suffer serious side effects or relapse. This shows the need for new cancer treatments that work better and cause fewer side effects to improve patients' lives.

Our Partners

  • European Union flag with yellow stars in a circle on a blue background, alongside text that reads "European Union European Regional Development Fund."
  • Keep+ logo with three overlapping circles in blue, purple, and pink.
  • NHS England logo with the words 'NHS' in blue and white and 'England' in black and white.
  • University of Hertfordshire logo with black text on a transparent background.
  • Brunel University London logo with a crest and the university name in blue text.
  • Queen Mary University of London logo with a crown.